Literature DB >> 25061170

Big bang theory of stem-like T cells confirmed.

Nicholas P Restifo1.   

Abstract

Mesh：

Year:  2014        PMID： 25061170      PMCID： PMC4110654          DOI： 10.1182/blood-2014-06-578989

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  10 in total

1.  Lowest numbers of primary CD8(+) T cells can reconstitute protective immunity upon adoptive immunotherapy.

Authors:  Christian Stemberger; Patricia Graef; Marcus Odendahl; Julia Albrecht; Georg Dössinger; Florian Anderl; Veit R Buchholz; Georg Gasteiger; Matthias Schiemann; Götz U Grigoleit; Friedhelm R Schuster; Arndt Borkhardt; Birgitta Versluys; Torsten Tonn; Erhard Seifried; Hermann Einsele; Lothar Germeroth; Dirk H Busch; Michael Neuenhahn
Journal:  Blood       Date:  2014-05-22       Impact factor: 22.113

Review 2.  T-cell memory differentiation: insights from transcriptional signatures and epigenetics.

Authors:  Ben Youngblood; J Scott Hale; Rafi Ahmed
Journal:  Immunology       Date:  2013-07       Impact factor: 7.397

Review 3.  CD8+ T-cell memory in tumor immunology and immunotherapy.

Authors:  Christopher A Klebanoff; Luca Gattinoni; Nicholas P Restifo
Journal:  Immunol Rev       Date:  2006-06       Impact factor: 12.988

4.  Host-reactive CD8+ memory stem cells in graft-versus-host disease.

Authors:  Yi Zhang; Gerard Joe; Elizabeth Hexner; Jiang Zhu; Stephen G Emerson
Journal:  Nat Med       Date:  2005-11-20       Impact factor: 53.440

5.  Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells.

Authors:  Christopher A Klebanoff; Luca Gattinoni; Parizad Torabi-Parizi; Keith Kerstann; Adela R Cardones; Steven E Finkelstein; Douglas C Palmer; Paul A Antony; Sam T Hwang; Steven A Rosenberg; Thomas A Waldmann; Nicholas P Restifo
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-24       Impact factor: 11.205

6.  Purification and characterization of mouse hematopoietic stem cells.

Authors:  G J Spangrude; S Heimfeld; I L Weissman
Journal:  Science       Date:  1988-07-01       Impact factor: 47.728

Review 7.  Lineage relationship of effector and memory T cells.

Authors:  Nicholas P Restifo; Luca Gattinoni
Journal:  Curr Opin Immunol       Date:  2013-10-20       Impact factor: 7.486

8.  A human memory T cell subset with stem cell-like properties.

Authors:  Luca Gattinoni; Enrico Lugli; Yun Ji; Zoltan Pos; Chrystal M Paulos; Máire F Quigley; Jorge R Almeida; Emma Gostick; Zhiya Yu; Carmine Carpenito; Ena Wang; Daniel C Douek; David A Price; Carl H June; Francesco M Marincola; Mario Roederer; Nicholas P Restifo
Journal:  Nat Med       Date:  2011-09-18       Impact factor: 53.440

9.  Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells.

Authors:  Luca Gattinoni; Steven E Finkelstein; Christopher A Klebanoff; Paul A Antony; Douglas C Palmer; Paul J Spiess; Leroy N Hwang; Zhiya Yu; Claudia Wrzesinski; David M Heimann; Charles D Surh; Steven A Rosenberg; Nicholas P Restifo
Journal:  J Exp Med       Date:  2005-10-03       Impact factor: 14.307

10.  Wnt signaling arrests effector T cell differentiation and generates CD8+ memory stem cells.

Authors:  Luca Gattinoni; Xiao-Song Zhong; Douglas C Palmer; Yun Ji; Christian S Hinrichs; Zhiya Yu; Claudia Wrzesinski; Andrea Boni; Lydie Cassard; Lindsay M Garvin; Chrystal M Paulos; Pawel Muranski; Nicholas P Restifo
Journal:  Nat Med       Date:  2009-06-14       Impact factor: 53.440
  10 in total
  8 in total

1.  β-catenin and PI3Kδ inhibition expands precursor Th17 cells with heightened stemness and antitumor activity.

Authors:  Kinga Majchrzak; Michelle H Nelson; Jacob S Bowers; Stefanie R Bailey; Megan M Wyatt; John M Wrangle; Mark P Rubinstein; Juan C Varela; Zihai Li; Richard A Himes; Sherine Sl Chan; Chrystal M Paulos
Journal:  JCI Insight       Date:  2017-04-20

2.  Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCT.

Authors:  M Neuenhahn; J Albrecht; M Odendahl; F Schlott; G Dössinger; M Schiemann; S Lakshmipathi; K Martin; D Bunjes; S Harsdorf; E M Weissinger; H Menzel; M Verbeek; L Uharek; N Kröger; E Wagner; G Kobbe; T Schroeder; M Schmitt; G Held; W Herr; L Germeroth; H Bonig; T Tonn; H Einsele; D H Busch; G U Grigoleit
Journal:  Leukemia       Date:  2017-01-16       Impact factor: 11.528

3.  Circulation of gut-preactivated naïve CD8+ T cells enhances antitumor immunity in B cell-defective mice.

Authors:  Maryam Akrami; Rosemary Menzies; Kenji Chamoto; Michio Miyajima; Ryuji Suzuki; Hiroyuki Sato; Akiko Nishii; Michio Tomura; Sidonia Fagarasan; Tasuku Honjo
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-09       Impact factor: 11.205

4.  MHC class II tetramer analyses in AE37-vaccinated prostate cancer patients reveal vaccine-specific polyfunctional and long-lasting CD4(+) T-cells.

Authors:  Eleftheria A Anastasopoulou; Ioannis F Voutsas; Michael Papamichail; Constantin N Baxevanis; Sonia A Perez
Journal:  Oncoimmunology       Date:  2016-05-02       Impact factor: 8.110

5.  Cytotoxic Efficiency of Human CD8+ T Cell Memory Subtypes.

Authors:  Arne Knörck; Gertrud Schäfer; Dalia Alansary; Josephine Richter; Lorenz Thurner; Markus Hoth; Eva C Schwarz
Journal:  Front Immunol       Date:  2022-04-13       Impact factor: 8.786

Review 6.  Chimeric antigen receptor-engineered T cells for the treatment of metastatic prostate cancer.

Authors:  Victoria Hillerdal; Magnus Essand
Journal:  BioDrugs       Date:  2015-04       Impact factor: 5.807

7.  PD-1 silencing impairs the anti-tumor function of chimeric antigen receptor modified T cells by inhibiting proliferation activity.

Authors:  Jianshu Wei; Can Luo; Yao Wang; Yelei Guo; Hanren Dai; Chuan Tong; Dongdong Ti; Zhiqiang Wu; Weidong Han
Journal:  J Immunother Cancer       Date:  2019-08-07       Impact factor: 13.751

Review 8.  Co-Stimulatory Blockade of the CD28/CD80-86/CTLA-4 Balance in Transplantation: Impact on Memory T Cells?

Authors:  Simon Ville; Nicolas Poirier; Gilles Blancho; Bernard Vanhove
Journal:  Front Immunol       Date:  2015-08-10       Impact factor: 7.561
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.